Quick jump to page content
Main Navigation
Main Content
Sidebar
Register
Login
Toggle navigation
Home
About
About the Journal
Submissions
Editorial Team
Privacy Statement
Contact
Current
Archives
Submission
Search
Search
Search articles for
Advanced filters
Published After
2017
2018
2019
2020
2021
2022
January
February
March
April
May
June
July
August
September
October
November
December
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Published Before
2017
2018
2019
2020
2021
2022
January
February
March
April
May
June
July
August
September
October
November
December
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
By Author
Search Results
Long-Term Efficacy of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: Data from a Pivotal Phase 3 Clinical Trial
Alan Menter, Jeff Sobell, Jonathan I Silverberg, Mark Lebwohl, Shipra Rastogi, Radhakrishnan Pillai, Robert J Israel
Page S9
Poster PDF
Improvement of Nail Psoriasis with Brodalumab in Phase 3 Trials
Mark G Lebwohl, Lawrence Green, Sylvia Hsu, Shipra Rastogi, Tina Lin, Radhakrishnan Pillai, Robert J Israel
Page s99
Poster PDF
Brodalumab in the treatment of moderate-to-severe psoriasis in patients refractory to anti-interleukin-17A therapies: Evaluation of secondary endpoints
Grace Kimmel, Margot Chima, Hee Jin Kim, Jennifer Bares, Alex Yaroshinsky, Giselle Singer, Soo Jung Kim, Jerry Bagel, Mark Lebwohl
Page 524-529
PDF
Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients with Moderate-to-Severe Psoriasis
Kristian Reich, Mark Lebwohl, Carle Paul, Mads Ropke, Monika Rosen, Klaus Hansen
Page S1
Poster PDF
Efficacy and Safety of Brodalumab in Obese Patients with Moderate-to-Severe Plaque Psoriasis
Abby S Van Voorhees, Sylvia Hsu, Boni Elewski, Shipra Rastogi, Robert J Israel
Page S7
Poster PDF
1 - 5 of 5 items
×
Modal Header
